ATEL Ventures

Founded in 1999, ATEL Ventures is a venture capital firm specializing in early to late-stage investments across information technology, life sciences, and green technologies. It provides secured financing services, focusing on growth capital term loans and equipment financing for emerging growth companies backed by top-tier investment firms.

Steven Rea

President, ATEL Growth Capital

James E. Ryan

VP

28 past transactions

Isar Aerospace

Debt Financing in 2024
Isar Aerospace is a space technology company focused on developing automated production methods for rockets. The company designs launch vehicles that facilitate the deployment and resupply of satellite constellations, aiming to provide low-cost and flexible access to space for small satellites. With an emphasis on sustainability, Isar Aerospace offers environmentally friendly solutions for propelling small launchers and upper-stage vehicles, thereby lowering entry barriers for clients seeking affordable and reliable space access.

Pendulum Therapeutics

Venture Round in 2023
Pendulum Therapeutics is a biotechnology company specializing in microbiome-targeted therapies. Founded in 2013 by experts in microbiology, biochemistry, computational science, and clinical research, the company develops evidence-based medical probiotics to manage chronic illnesses, with a focus on type 2 diabetes. Its flagship product, Pendulum Glucose Control, has demonstrated efficacy in lowering blood sugar spikes and reducing A1C levels in clinical trials.

ARRIS

Venture Round in 2023
ARRIS specializes in developing additive molding technology for manufacturing large-scale 3D-aligned continuous fiber thermoplastic composite parts. Its innovative process combines aligned fibers, electronics, and metallic components within topology-optimized structures, serving industries such as aerospace, automotive, and consumer products.

Astranis

Debt Financing in 2023
Astranis develops innovative satellite technology to provide targeted internet access to underserved regions. The company manufactures small satellites for high-orbit deployment, serving diverse sectors such as defense, commercial communications, oil and gas, and telecommunications.

Plant Prefab

Debt Financing in 2022
Plant Prefab specializes in custom single and multi-family home construction services using advanced digital modeling and prefabrication methods. Their Plant Building System enables contractors and developers to build homes up to 50% faster than traditional on-site methods, with improved quality control, design flexibility, and efficiency. Committed to sustainability, the company aims to achieve net-zero housing production and has maintained carbon-neutral operations since 2020.

Hexagon Bio

Venture Round in 2022
Hexagon Bio, Inc. is a biotechnology company that specializes in discovering novel small molecule therapeutics by mining genomic data from fungal genomes. Founded in 2016 and headquartered in Menlo Park, California, Hexagon Bio leverages a proprietary platform that integrates data science, synthetic biology, and automation to identify and engineer drugs. The company's innovative approach focuses on developing targeted therapies for diseases with unmet medical needs by searching for evolutionarily refined molecules and their associated protein targets. Through its unique methodology, Hexagon Bio aims to uncover new medicines encoded within the global metagenome, ultimately striving to improve patient outcomes.

Activ Surgical

Series B in 2022
Activ Surgical is a Boston-based digital surgery company developing a surgical imaging and software platform that uses computer vision, artificial intelligence, analytics, and machine learning to assist surgeons in complex procedures, enhance intraoperative decision-making, improve efficiency and accuracy, and reduce unintended complications. The platform supports augmented reality-based guidance and AI-driven surgery, and its robotic initiatives include the Smart Tissue Autonomous Robot, a system designed to automate aspects of tissue manipulation during surgery.

Function of Beauty

Venture Round in 2022
Founded in 2015, Function of Beauty specializes in personalized hair care products. Customers can create customized shampoos, conditioners, and styling products based on their unique hair type, goals, and aesthetic preferences. The company's formulations are free from sulfates, parabens, phthalates, and other potentially harmful ingredients.

Apeel Sciences

Debt Financing in 2022
Apeel Sciences, based in California, addresses the global food waste crisis by developing plant-derived solutions that extend the shelf life of fresh produce. Founded in 2012, the company creates pre-and post-harvest products using natural plant extracts, such as Edipeel and Invisipeel, which protect fruits and vegetables from environmental factors and pre-harvest issues. These innovations effectively double the lifespan of harvested crops without refrigeration, helping to reduce spoilage and conserve resources like water and energy. By leveraging materials found in the skins, peels, and seeds of fruits and vegetables, Apeel aims to minimize food waste and promote sustainability throughout the supply chain. The company's efforts are supported by a range of private investors and philanthropic organizations.

Lightship

Series C in 2021
Founded in 2018, Lightship aims to enhance health equity globally by transforming clinical trials. It combines digital health innovations, technology, remote care, and high-quality clinical research to make studies more accessible and offer choices, keeping patients at the core of its work.

Plant Prefab

Debt Financing in 2021
Plant Prefab specializes in custom single and multi-family home construction services using advanced digital modeling and prefabrication methods. Their Plant Building System enables contractors and developers to build homes up to 50% faster than traditional on-site methods, with improved quality control, design flexibility, and efficiency. Committed to sustainability, the company aims to achieve net-zero housing production and has maintained carbon-neutral operations since 2020.

Iron Ox

Series A in 2019
Iron Ox, Inc. is an innovative company that specializes in developing robotics for crop harvesting and sustainable indoor farming systems. Founded in 2015 and headquartered in San Carlos, California, Iron Ox operates greenhouses in Gilroy, California, and Lockhart, Texas. The company utilizes a combination of robotics, plant science, and machine learning to cultivate fresh, pesticide-free produce, including various leafy greens and culinary herbs. Their flagship product, Angus, is an autonomous farm mobile robot designed to enhance agricultural efficiency. By focusing on sustainable practices, Iron Ox aims to minimize agriculture's environmental impact while improving the availability, quality, and flavor of its products for consumers.

Emulate

Series B in 2016
Emulate is a biotechnology company that develops organ-on-a-chip human emulation technology to model how diseases, medicines, chemicals, and foods affect human health. Its platform includes lung, intestinal, liver, and skin organ chips that reproduce normal biology and disease states, enabling human-relevant insights beyond traditional cell culture or animal models. The company also provides drug development tools and instrumentation software to support research and development workflows for researchers across biotechnology, pharmaceutical, consumer health, cosmetics, chemical, food, and agrochemical sectors, as well as government agencies and academic institutions. Founded in 2013 and headquartered in Boston, Emulate aims to accelerate understanding of human biology and improve human health outcomes.

Emulate

Series B in 2016
Emulate is a biotechnology company that develops organ-on-a-chip human emulation technology to model how diseases, medicines, chemicals, and foods affect human health. Its platform includes lung, intestinal, liver, and skin organ chips that reproduce normal biology and disease states, enabling human-relevant insights beyond traditional cell culture or animal models. The company also provides drug development tools and instrumentation software to support research and development workflows for researchers across biotechnology, pharmaceutical, consumer health, cosmetics, chemical, food, and agrochemical sectors, as well as government agencies and academic institutions. Founded in 2013 and headquartered in Boston, Emulate aims to accelerate understanding of human biology and improve human health outcomes.

Ionic Materials

Venture Round in 2015
Ionic Materials, Inc. is a Woburn, Massachusetts-based company that specializes in the development of solid polymer electrolyte materials for batteries. Founded in 1986, the company leverages a technology team with extensive expertise in polymer science and electrochemistry to create a groundbreaking polymer electrolyte that enhances battery safety, performance, and cost-effectiveness. This innovation challenges traditional battery design, which often requires trade-offs among safety, cost, and performance. Ionic Materials aims to address the needs of various industries by providing solutions that enable original equipment manufacturers and other manufacturers to innovate and meet market demands without the burden of developing new materials independently. By collaborating with core partners in the battery industry, Ionic is focused on bringing its advanced technology to market.

Edeniq

Venture Round in 2012
Founded in 2008, Edeniq specializes in developing technologies for producing cellulosic ethanol from corn kernel fiber. Its Intellulose platform enables existing ethanol plants to produce additional cellulosic ethanol with zero capital investment.

iPierian

Series B in 2010
iPierian is a biotechnology company specializing in the development of therapies for neurodegenerative diseases. Utilizing induced pluripotent stem cells, the company focuses on addressing significant unmet medical needs, particularly in conditions such as spinal muscular atrophy, amyotrophic lateral sclerosis, and Parkinson's disease. iPierian is engaged in the research and development of innovative therapies, including monoclonal antibodies aimed at treating Alzheimer's disease and other Tauopathies. By targeting the mechanisms that drive disease progression, the company aims to provide physicians with effective tools to slow the spread of Tau in the brain, thereby potentially improving patient outcomes.

SolFocus

Venture Round in 2010
SolFocus's mission is to enable solar energy generation at a Levelized Cost of Energy (LCOE) competitive with traditional fossil fuel sources. To achieve this goal, SolFocus has developed leading concentrator photovoltaic (CPV) technology which combines high-efficiency solar cells (approaching 40%) and advanced optics to provide solar energy solutions which are scalable, dependable and capable of delivering on the promise of clean, low-cost, renewable energy.

NexPlanar

Debt Financing in 2010
NexPlanar Corporation specializes in the manufacturing of chemical mechanical planarization (CMP) pads for the semiconductor device industry. Founded in 2003 and based in Hillsboro, Oregon, the company also operates a manufacturing facility in Hopkins, Minnesota. NexPlanar's innovative products, which include hard, mid-hard, and ultra-soft pads, utilize proprietary nano-domain technology and patented molded grooves to enhance the efficiency of semiconductor fabrication processes. This technology allows for the tuning of pads to achieve improved yields and lower costs of ownership through extended pad life. Originally known as Neopad Technologies Corporation, the company rebranded to NexPlanar in September 2008 and has since become a subsidiary of Cabot Microelectronics Corporation.

IntelePeer

Venture Round in 2009
IntelePeer is a communications automation platform that utilizes generative AI to enhance customer interactions for businesses. By offering a cloud-based Communications Platform as a Service (CPaaS), the company provides on-demand IP communications and SIP trunking services tailored for enterprises. IntelePeer's platform integrates seamlessly with existing systems, allowing businesses to streamline their communication processes across multiple channels. Its focus on automation not only reduces operational costs but also improves customer experience by delivering efficient and effective communication solutions. The incorporation of AI and analytics further enhances the platform's capabilities, enabling clients to achieve higher levels of customer satisfaction and engagement.

OpSource

Venture Round in 2009
Dimension Data, formerly known as OpSource, is a provider of cloud and managed hosting solutions designed to help businesses of all sizes accelerate growth and scale operations effectively. Established in 2002, the company offers a comprehensive Application Operations service that surpasses traditional hosting by delivering application management, change management, performance management, and application optimization. This approach allows clients to benefit from the flexibility, availability, and community of public cloud services while ensuring the security, performance, and control required by enterprise environments. Dimension Data is certified with SAS 70 Type II, PCI DSS Level 1, and adheres to European Safe Harbor standards, with operations in California, Virginia, the UK, Ireland, and India. The company supports over four hundred Software-as-a-Service independent software vendors, cloud platform providers, carriers, and enterprises, enabling them to manage high-availability, business-critical hosting environments efficiently.

Enerkem

Venture Round in 2009
Enerkem transforms non-recyclable waste into renewable biofuels and chemicals. Its proprietary thermochemical process converts municipal solid waste into biofuels like ethanol, addressing oil dependence and waste disposal challenges.

GangaGen

Seed Round in 2008
GangaGen is a clinical-stage biotechnology company focused on discovering and developing therapeutic proteins to prevent and treat infectious diseases, with emphasis on antibiotic-resistant bacteria such as MRSA. Using a proprietary ectolysin platform, it develops highly specific proteins that target harmful bacteria, with lead candidate P128 designed to bind to and kill Staphylococcus, including MRSA. The company has pursued topical therapies such as StaphTAME for prevention and treatment of staphylococcal infections and aims to address unmet clinical needs by offering non-traditional antibacterial agents. GangaGen is based in Palo Alto, California, with research and development activities in Bangalore, India.

Innovalight

Venture Round in 2008
Innovalight, founded by Conrad Burke, specializes in the development of high-efficiency, low-cost solar modules aimed at both residential and commercial applications. The company is notable for its innovative approach to solar technology, utilizing a proprietary silicon ink that has been in development since 2005. This liquid-based processing method significantly enhances the cost-effectiveness and efficiency of solar modules compared to traditional solid or gas processing techniques. Innovalight's focus on ultra thin-film power modules positions it as a key player in the solar energy sector, particularly in the realm of grid-connected solar power generation.

Axial Biotech

Debt Financing in 2008
Axial Biotech is a privately held, venture-backed company founded in 2002 by a group of internationally recognized spine surgeons and geneticists. Axial Biotech is focused on developing and commercializing genetic tests and treatment solutions for spinal disorders.

BuyerLink

Series C in 2007
BuyerLink operates an online marketing platform that enables advertisers and publishers to acquire locally targeted, category-specific consumers through cost-per-click or cost-per-lead campaigns. The platform provides widgets for automotive, real estate, home improvement, mortgage, travel, and insurance, serving businesses of all sizes by eliminating the need for complex and expensive online marketing infrastructures and offering a cost-efficient alternative to major search engines and ad networks. Founded in 2001 and based in Walnut Creek, California, the company originated as Reply.com and rebranded to BuyerLink in 2015, focusing on making internet marketing accessible for local and category-specific campaigns and facilitating efficient lead generation for advertisers.

Cornice

Funding Round in 2006
Cornice, Inc. provides storage elements for consumer electronics devices. Its storage element is built into various consumer products, including mobile phones, MP3 players, personal video recorders, GPS devices, and portable storage products. The company offers Crash Guard, which consists of active latch, skip control, and drop safe. It serves consumer electronics manufacturers. The company was founded in 2000 and is headquartered in Longmont, Colorado with integration centers in Hong Kong, Japan, and Taiwan.

Aryx Therapeutics

Series D in 2004
Aryx Therapeutics is a biopharmaceutical company that specializes in the development of innovative oral therapies aimed at chronic diseases. The company leverages its expertise in retrometabolic drug design to create product candidates that address and eliminate safety concerns associated with existing, commercially successful medications. By focusing on improving the safety profiles of these therapies, Aryx Therapeutics seeks to enhance patient outcomes and provide better treatment options in the pharmaceutical market. The company's commitment to advancing drug safety is supported by a strong portfolio of intellectual property.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.